Ten years after the U.S. government began trying to ensure children's prescription drugs were safe, doctors still have little information to guide them.
While federal regulators have induced pharmaceutical companies to conduct hundreds of studies on some 200 drugs, another two-thirds of the thousands of children's medicines remain untested, The Washington Post reported Friday.
"Are there children dying because of this? I don't know. Are there children being less effectively treated because of this? Probably, yes," Richard Gorman of the American Academy of Pediatrics said in the Post. "That's the problem: We don't know what we don't know."
The gap in medical knowledge has varied roots. Testing of drugs on children was deemed unnecessary and unethical for decades; government and drug houses provided inadequate funding; and medical testing on children is difficult.
One help was the 2003 Pediatric Research Equity Act, which authorized the Food and Drug Administration to require companies to test new drugs on before they are approved for sale and provided incentives for drug companies to conduct studies, enabling the FDA to give doctors specific advice on at least 138 drugs, the Post said.
Copyright 2007 by United Press International
Related stories:
Researchers clarify function of glucose transport molecule
Researchers at the David Geffen School of Medicine at UCLA have solved the structure of a class of proteins known as sodium glucose co-transporters (SGLTs), which pump glucose into cells. These transport proteins are used in the treatment of chronic diarrhea via oral rehydration therapy, saving the lives of millions of children each year. The solution of the SGLT structure will accelerate development of new drugs designed to treat patients with diabetes and cancer.
'Neglected infections of poverty' in US disable hundreds of thousands of Americans annually
An analysis published June 25th in the open-access journal
PLoS Neglected Tropical Diseases highlights that diseases very similar to those plaguing Africa, Asia, and Latin America are also occurring frequently among the poorest people in the United States, especially women and children. These diseases — the "neglected infections of poverty" — are caused by chronic and debilitating parasitic, bacterial, and congenital infections.
Researchers identify biofilms that cause infections
Understanding the way bacterial cells "talk" to each other could lead to more effective methods for fighting the often persistent and serious infections caused by the biofilms they form, says a Texas A&M University professor of chemical engineering who not only has deciphered their language but also discovered how to quell their conversation.
Micro-origami: Researchers fold up micrometer-scale 'voxels' for drug delivery
Researchers at the USC Information Sciences Institute have demonstrated a way to manufacture miniscule closed containers that might be used to deliver precise micro- or even nano-quantities of drugs.
Lombardi Comprehensive Cancer Center publishes manual for childhood cancer survivors
With more than 270,000 childhood cancer survivors living in the United States, researchers have turned their attention to the effects of cancer treatment that can occur years after therapy, called late effects. At the Lombardi Comprehensive Cancer Center and Georgetown University Hospital, a team of oncologists, nurses, social workers and an art therapist have created the first survivorship manual, tailored for each child treated for cancer. The Next Step… Crossing the Bridge to Survivorship is an educational guide designed to provide specific information related to long-term follow-up and survivorship.
Lack of political will and the subordination of women are major barriers to tackling AIDS
Denial, myths, complacency, lack of political will and the subordination of women are major obstacles in the fight against HIV and AIDS. And with no cure or vaccine in sight, scaling up prevention is of paramount importance, according to Professor Lars Kallings, a leading expert in the global fight against the world’s first modern pandemic.
New treatment boosts bone healing and regrowth
A drug originally used to treat iron poisoning can significantly boost the body’s own ability to heal and re-grow injured bones, according to researchers at the University of Alabama at Birmingham (UAB).
Study suggests some brain injuries reduce the likelihood of post-traumatic stress disorder
A new study of combat-exposed Vietnam War veterans shows that those with injuries to certain parts of the brain were less likely to develop post-traumatic stress disorder (PTSD). The findings, from the National Institutes of Health (NIH) and the National Naval Medical Center, suggest that drugs or pacemaker-like devices aimed at dampening activity in these brain regions might be effective treatments for PTSD.